Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Next Breath LLC
EIR
•Next Breath LLC•February 23, 2018

Next Breath LLC – FDA EIR, Feb 23, 2018

Record Details

An FDA bioanalytical surveillance inspection of Next Breath, a Division of Aptar Group, Inc., took place in Baltimore, MD, from February 13-23, 2018. The inspection, conducted under Compliance Program 7348.001 for in vivo bioequivalence, focused on analytical records and method validations for bioequivalence studies related to ANDAs. Although no Form FDA 483 was issued, the FDA investigator discussed several critical observations with company management. Main issues identified included deficiencies in Quality Control (QC) sample representation during HPLC analysis for Aerosol Particle Size Distribution (APSD) tests, with sensitivity solution recovery outside established criteria in multiple runs. The HPLC method validation for APSD was found to have an insufficient range to cover expected sample concentrations. Additionally, a large number of manual integrations in HPLC chromatograms lacked the required justification and approval per the company’s Standard Operating Procedures. A significant compliance concern was the unblinding of test and reference product information during Droplet Size Distribution (DSD) testing by an analyst, compromising study integrity. Next Breath’s management acknowledged these findings and committed to implementing corrective actions. These include updating future HPLC analytical runs to incorporate QCs spanning the full concentration range, ensuring comprehensive method validation reports, strictly adhering to manual integration procedures with proper documentation, and maintaining product blinding in all future bioequivalence studies.

Company
Next Breath LLC
Inspection date
February 23, 2018
Product type
drugs
Office
Baltimore District Office
People
  • Julie D. Suman (recipient)
  • Xiaohan Cai (investigator)
  • Francois Billard (company_representative)
  • Kimberley Maclean (company_representative)
View Company Profile

ID · cae70a99-7ab3-47a6-a195-7a74f80a3eca

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Next Breath LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.